Log In
BCIQ
Print this Print this
 

PRX-ASL

  Manage Alerts
Collapse Summary General Information
Company PhaseRx Inc.
DescriptionIntracellular enzyme replacement therapy
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationUrea cycle disorder (UCD)
Indication DetailsTreat argininosuccinate lyase deficiency (ASL)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today